Case 31-2012: An 18-year-old man with blurred vision, dysarthria, and ataxia

New England Journal of Medicine

Volumn 367, Issue 15, 2012, Pages 1450-1460

  Yager, Phoebe H ^a,b   Singhal, Aneesh B ^a,b   Nogueira, Raul G ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LUPUS ANTICOAGULANT; WARFARIN;

ADULT; ARTERY CATHETER; ARTICLE; ATAXIA; BASILAR ARTERY OBSTRUCTION; BLURRED VISION; BRAIN ISCHEMIA; CASE REPORT; COMA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DYSARTHRIA; ENDOTRACHEAL INTUBATION; ENDOVASCULAR REPERFUSION; HUMAN; INVASIVE PROCEDURE; ISCHEMIC BRAIN STEM STROKE; LUMBAR PUNCTURE; MALE; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PATENT FORAMEN OVALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; SEPTAL OCCLUDER; THROMBUS ASPIRATION; ACUTE DISEASE; ADOLESCENT; BASILAR ARTERY; CEREBROVASCULAR ACCIDENT; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; MECHANICAL THROMBECTOMY; RADIOGRAPHY; THROMBOEMBOLISM; VISUAL DISORDER;

ACUTE DISEASE; ADOLESCENT; ATAXIA; BASILAR ARTERY; BRAIN ISCHEMIA; COMA; DIAGNOSIS, DIFFERENTIAL; DYSARTHRIA; FORAMEN OVALE, PATENT; HUMANS; MALE; MECHANICAL THROMBOLYSIS; RISK FACTORS; STROKE; THROMBOEMBOLISM; VISION DISORDERS;

EID: 84867209750     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1208150     Document Type: Article

References (45)

1. Liang JT, Huo LR, Bao YH, Zhang HQ, Wang ZY, Ling F. Intracranial aneurysms in adolescents. Childs Nerv Syst 2011;27:1101-7.
2. de Ribaupierre S, Rilliet B, Cotting J, Regli L. A 10-year experience in paediatric spontaneous cerebral hemorrhage: which children with headache need more than a clinical examination? Swiss Med Wkly 2008;138:59-69.
3. Su TM, Lan CM, Tsai YD, Lee TC, Lu CH, Chang WN. Multiloculated pyogenic brain abscess: experience in 25 patients. Neurosurgery 2003;52:1075-80.
4. Shellhaas RA, Smith SE, O'Tool E, Licht DJ, Ichord RN. Mimics of childhood stroke: characteristics of a prospective cohort. Pediatrics 2006;118:704-9.
5. Wolff V, Lauer V, Rouyer O, et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke 2011;42:1778-80.
6. Christo PP, Silva JS, Werneck IV, Dias SL. Rhombencephalitis possibly caused by Mycoplasma pneumoniae. Arq Neuropsiquiatr 2010;68:656-8.
7. Daxboeck F, Blacky A, Seidl R, Krause R, Assadian O. Diagnosis, treatment, and prognosis of Mycoplasma pneumoniae childhood encephalitis: systematic review of 58 cases. J Child Neurol 2004;19:865-71.
8. Quintero-Del-Rio AI, Miller V. Neurologic symptoms in children with systemic lupus erythematosus. J Child Neurol 2000;15:803-7.
9. Rafay MF, Pontigon AM, Chiang J, et al. Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke 2009;40:58-64.
10. Goldmakher GV, Camargo EC, Furie KL, et al. Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation stroke. Stroke 2009;40:134-9.
11. Adams HP Jr, Kappelle LJ, Biller J, et al. Ischemic stroke in young adults: experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol 1995;52:491-5.
12. Kittner SJ, McCarter RJ, Sherwin RW, et al. Black-white differences in stroke risk among young adults. Stroke 1993;24:Suppl:I-13-I-15, I-20-I-21.
13. Kristensen B, Malm J, Carlberg B, et al. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 1997;28:1702-9.
14. Kittner SJ, Stern BJ, Wozniak M, et al. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998;50:890-4.
15. Jacobs BS, Boden-Albala B, Lin IF, Sacco RL. Stroke in the young in the northern Manhattan stroke study. Stroke 2002;33:2789-93.
16. Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009;40:1195-203.
17. Ji R, Schwamm LH, Muhammad P, Singhal AB. Ischemic stroke and TIA in young adults: risk factors, diagnostic yield, neuroimaging and thrombolysis. Arch Neurol (in press).
18. George MG, Tong X, Kuklina EV, Labarthe DR. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995-2008. Ann Neurol 2011;70:713-21.
19. Mehndiratta MM, Agarwal P, Sen K, Sharma B. Stroke in young adults: a study from a university hospital in north India. Med Sci Monit 2004;10:CR535-CR541.
20. Mackay MT, Wiznitzer M, Benedict SL, Lee KJ, Deveber GA, Ganesan V. Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol 2011;69:130-40.
21. Kuruvilla A, Bhattacharya P, Rajamani K, Chaturvedi S. Factors associated with misdiagnosis of acute stroke in young adults. J Stroke Cerebrovasc Dis 2011;20:523-7.
22. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
23. Singhal AB. Diagnostic challenges in RCVS, PACNS, and other cerebral arteriopathies. Cephalalgia 2011;31:1067-70.
24. Putaala J, Haapaniemi E, Metso AJ, et al. Recurrent ischemic events in young adults after first-ever ischemic stroke. Ann Neurol 2010;68:661-71.
25. Putaala J, Haapaniemi E, Kaste M, Tatlisumak T. How does number of risk factors affect prognosis in young patients with ischemic stroke? Stroke 2012;43:356-61.
26. Morris JG, Singh S, Fisher M. Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke 2010;41:2985-90.
27. Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke 2007;38:2979-84.
28. Chatzikonstantinou A, Wolf ME, Hennerici MG. Ischemic stroke in young adults: classification and risk factors. J Neurol 2012;259:653-9.
29. Larrue V, Berhoune N, Massabuau P, et al. Etiologic investigation of ischemic stroke in young adults. Neurology 2011;76:1983-8.
30. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis 2009;27:502-8.
31. Putaala J, Metso TM, Metso AJ, et al. Thrombolysis in young adults with ischemic stroke. Stroke 2009;40:2085-91.
32. Poppe AY, Buchan AM, Hill MD. Intravenous thrombolysis for acute ischaemic stroke in young adult patients. Can J Neurol Sci 2009;36:161-7.
33. Toni D, Ahmed N, Anzini A, et al. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Neurology 2012;78:880-7.
34. Nogueira RG, Yoo AJ, Buonanno FS, Hirsch JA. Endovascular approaches to acute stroke. 2. A comprehensive review of studies and trials. AJNR Am J Neuroradiol 2009;30:859-75.
35. Khatri P, Hill MD, Palesch YY, et al. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008;3:130-7.
36. Smith WS. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007;38:Suppl:701-3.
37. Macleod MR, Davis SM, Mitchell PJ, et al. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 2005;20:12-7.
38. Schonewille WJ, Wijman CA, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol 2009;8:724-30.
39. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254-8.
40. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007;24:1-10.
41. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005;172:1307-12.
42. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
43. Ribo M, Molina CA, Rovira A, et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005;36:602-6.
44. Thomalla G, Sobesky J, Kohrmann M, et al. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Stroke 2007;38:313-8.
45. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703.